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GlutathioneThe mitochondriotropic compound 7-O-(4-triphenylphosphoniumbutyl)quercetin iodide (Q-7BTPI) in the
μM concentration range caused necrotic death of cultured cells by acting as a prooxidant, with generation
of superoxide anion in the mitochondria. Externally added membrane-permeating superoxide dismutase or
catalase largely prevented death. Rescue by permeant catalase indicates that the toxicant is H2O2, or reactive
species derived from it. Rescue by permeant dismutase suggests the possibility of a chain mechanism of H2O2
production, in which dismutation of superoxide constitutes a termination step. Oxidative stress was due to
the presence of free phenolic hydroxyls and to accumulation in mitochondria, since the analogous mitochon-
driotropic per-O-methylated compound -3,3′,4′,5-tetra-O-methyl,7-O-(4-triphenylphosphoniumbutyl)
quercetin iodide (QTM-7BTPI)—or Quercetin itself induced no or little superoxide production and cell
death. Q-7BTPI did not cause a signiﬁcant perturbation of the mitochondrial transmembrane potential or of
respiration in cells. On the other hand its presence led to inhibition of glutathione peroxidase, an effect
expected to accentuate oxidative stress by interfering with the elimination of H2O2. An exogenous permeable
glutathione precursor determined a strong increase of cellular glutathione levels but did not rescue the cells.
Death induction was selective for fast-growing C-26 tumoral cells and mouse embryonic ﬁbroblasts (MEFs)
while sparing slow-growing MEFs. This suggests a possible use of Q-7BTPI as a chemotherapeutic agent.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mitochondrial ROS are important second messengers in the cell,
and bear partial responsibility for aging, oncogenesis, diabetes, neu-
rodegenerative disorders and ischemic damage [1]. Hence the current
interest in mitochondria-targeted redox agents. These compounds
have been generally conceived as protective anti-oxidants and have
been shown to act as such in several experimental systems (revs.,
[2–5]). Reports of cytotoxic and pro-oxidant effects are few. The, 1,2-Bis(2-aminophenoxy)ethane-N
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mitocans—interacts with mitochondrial succinate dehydrogenase at
a coenzyme Q10 binding site, interfering with the normal ﬂow of
electrons along the respiratory chain and diverting a portion of
them to the production of superoxide [6]. This results in cytotoxicity
which has been found to offer promise against cancer in in vivo stud-
ies [7]. Introduction of a triphenylphosphonium group (TPP) in the
structure to promote mitochondrial delivery increases the efﬁcacy
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mitochondriotropic redox-active compound, has been shown to act
as an anti-oxidant [5,9]. It can nonetheless act as a pro-oxidant in
vitro, causing an important production of ROS by cultured cells [10].
Since both pro- and anti-oxidant behaviors descend from the
same physico-chemical property, namely a relatively low oxidation
potential, this “dichotomy” is not surprising and is to be expected a
priori also for the mitochondriotropic polyphenol derivatives under
development by our group [11–14]. With polyphenols, one or the
other mode of action prevails depending on structural details and
on circumstances such as the presence of catalysts (often metal
ions) that can induce redox cycling, and the concentration of the
redox-active species itself [15–19]. Increasing attention is now
being paid to the phenomenon of hormesis, an adaptive response to
low-level stress affording protection against stronger subsequent
challenges (e.g. [20]). The anti-oxidant effects of phytocompounds
have been attributed to such an hormetic mode of action in many
cases (e.g. [20,21]).
The mitochondriotropic Quercetin derivative 7-O-(4-triphenylpho-
sphoniumbutyl)quercetin iodide (Q-7BTPI) has been recently synthe-
sised in our group [22]. Unlike its isomer Q-3BTPI, it has essentially
the same oxidation potential and the same stoichiometry of reaction
with the DPPH radical as Quercetin [12]. We report here on its effects
on cultured cells.
2. Materials and methods
Experiments were performed at least in triplicate, and averages±
s.d. are reported. Signiﬁcance (p) in comparisons was assessed using
the Wilcoxon Rank Test.
2.1. Materials
Quercetin and other commercial chemicals were purchased from
Sigma-Aldrich (Milan) unless otherwise speciﬁed. Chemicals for
buffer preparations were of laboratory grade, obtained from J. T.
Baker,Merck, or Sigma. Q-7BTPIwas synthesized as previously reported
[22].
2.2. Cells
Fast- (doubling time 16 h) and slow- (doubling time 3 days)
growing SV-40 immortalized Mouse Embryo Fibroblast (MEF) cells
and mouse colon cancer C-26 cells (doubling time 24 h) wereD E F
10 µm
A B C
10 µm
Fig. 1. Representative ﬂuorescence microscope (A, B, C; λexc: 340 nm; λem: >400 nm) and c
cells. Fluorescence is rendered on the greyscale for clarity. A, D) just before the addition of
Q-7BTPI 5 μM; C, F) 10 min after the addition of 2 μM FCCP. G) Chemical structure of Q-7BTgrown in Dulbecco's Modiﬁed Eagle Medium (DMEM) plus 10 mM
HEPES buffer (pH 7.4), 10% (v/v) fetal calf serum (Invitrogen),
100 U/mL penicillin G, 0.1 mg/mL streptomycin, 2 mM glutamine
(GIBCO) and 1% nonessential amino acids (100×solution; GIBCO),
in a humidiﬁed atmosphere of 5% CO2 at 37 °C. Jurkat T lymphocytes
(doubling time 24 h) were grown in RPMI-1640 supplemented as
above.2.3. Fluorescence microscopy
In solution, Q-7BTPI absorbs in the UV. We could not use this part
of the absorption spectrum to image it using the available light
sources in confocal microscopes, and only a weak ﬂuorescence
could be observed in cells using a standard ﬂuorescence microscope
exciting at the shortest available wavelength (340 nm). However,
analogously to what has been observed with Quercetin [23], upon
binding to cellular components Q-7BTPI absorbs some light also in
the cyan region, ﬂuorescing in the green. This is not the case for
QTM-7BTPI, which however has a stronger ﬂuorescence when excited
at 340 nm . We were therefore able to observe a weak Q-7BTPI
ﬂuorescence in cells by confocal microscopy, exciting at 488 nm. For
the experiments on the cellular localization of Q-7BTPI (Fig. 1) or
QTM-7BTPI (Supplementary Fig. 4) cells were seeded onto 24-mm
coverslips in 6-well plates and grown for about two days in DMEM.
Coverslips were mounted onto holders, washed, covered with 1 mL
of DMEM without serum and Phenol Red and supplemented with
2 μM CSA, and placed on the microscope stage. When a standard ﬂuo-
rescence microscope (an Olympus Biosystems apparatus comprising
an Olympus IX71 microscope and MT20 light source) was used
(Fig. 1A–C), images were acquired automatically at 1- or 2-min inter-
vals and processed with CellR© software. Excitation was at 340±
15 nm and ﬂuorescence was collected at λ>400 nm. For confocal mi-
croscopy (Fig. 1D–F) we used a Leica SP2 microscope with a 63× oil
immersion objective. Excitation was at 488 nm and ﬂuorescence
was collected in the 530–590 nm interval. To avoid bleaching, in the
presence of Q-7BTPI the ﬁeld of view was only illuminated twice: at
a set time after the addition of Q-7BTPI to the cells, and again after ad-
dition of FCCP. Resolution was 1024×1024 and line scan frequency
was 200 Hz. Control experiments showed that two illuminations of
a ﬁeld with these parameters did not cause an appreciable quenching
of ﬂuorescence. Additions were performed by withdrawing 0.5 mL of
incubation medium, adding the desired solute to this aliquot,
mixing, and adding back the solution into the chamber at a peripheralQ-7BTPI
G
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I
onfocal (D, E, F; λexc: 488 nm; λem: 530–590 nm) images of cultured slow growing MEF
Q-7BTPI; B) 20 min after the addition of Q-7BTPI 20 μM; E) 1.5 h after the addition of
PI.
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parameters; ﬂuorescence intensities can thus be compared.
2.4. Cell growth/viability MTT assays
These experiments were intended to compare the effects of the
compounds on cells with different origin and proliferation rates.
These effects are expected to depend not on the absolute concentration
of compound in the growth medium, but rather on the amount
accumulated by the cells, which is inversely related to the number of
cells in the assay. The latter in turn changes with a different time course
due to the different doubling times of the cultures. Furthermore, in
assays with slow-growing cells it was necessary to begin the culture
with a more numerous population in order to obtain signiﬁcant
readout values. Results must therefore be considered as of only
semi-quantitative signiﬁcance.
C-26 or MEF cells were seeded in standard 96-well plates and
allowed to grow in DMEM+10% FCS (200 μL) for 16–18 h to ensure
attachment. Initial densities were 1000 or 3000 (for C-26 and
fast-growing MEF) or 2500 (slow-growing MEF) cells/well. After the
initial attachment period the growth medium was replaced with
medium containing the desired compound at 1, 3 or 5 μM from
stock solutions in DMSO. DMSO ﬁnal concentration was 0.1% in all
cases (including controls). Individual experiments were performed
in quadruplicate, i.e., four wells were used for each of the compounds
to be tested. Cells were incubated with the compounds for 72 h; the
solution was substituted by a fresh aliquot twice, at 24 h intervals.
At the end of the incubation period, the medium was removed and
substituted with 100 μl of PBS plus 10 μL of CellTiter 96® solution
(Promega; for details: www.promega.com/tbs). After a 1-h color
development period at 37 °C absorbance at 490 nm was measured
using a Packard Spectra Count 96-well plate reader.
2.5. Annexin/PI labeling assays
Cell death was determined by staining cells with Annexin V-FLUOS
(Roche) and Propidium Iodide (PI) (Sigma) and ﬂuorescence analysis
by ﬂow cytometry. Jurkat lymphocytes were used to avoid cell
aggregations and possible damage due to procedures associated with
the detachment of adherent cells. A Beckton Dickinson Canto II ﬂow
cytometer was used. Cells were washed in HBSS and resuspended at
3×105 cells/mL in DMEM without serum and Phenol Red, or in some
experiments in HBSS. Aliquots were incubated for 3 h with the desired
compounds at 37 °C, 5% CO2. DMSO concentration was 0.2% in all cases.
A 200-μL portion of each incubation was then placed in a test tube and
Propidium Iodide (ﬁnal concentration 1 μg/mL) and annexin-V-FLUOS
(Roche; cat. N. 11 828 681 001) (1 μL/sample) were added. FACS
analysis was carried out after a further 20 min labeling period at
37 °C in the dark. 5000 cells were counted for each measurement.
Data were processed by quadrant statistics using BD VISTA software.
For presentation purposes, the percentage of unlabeled cells in the
control sample of each experiment has been set as 100%.
2.6. ROS production assays
Superoxide generation in cells was assessed in ﬂow cytometry
(FACS) experiments using the mitochondriotropic superoxide
anion-speciﬁc probe MitoSOX Red® (Invitrogen/Molecular Probes).
Jurkat cells were washed and resuspended in HBSS at a density of
1.5×106 cells/mL and loaded with 1 μM MitoSOX Red® (37 °C,
20 min). Cyclosporin A (CsA) (5 μM) was generally included as an
inhibitor of MDR pumps, to obtain a higher accumulation ratio for
the dye and to limit the rate of efﬂux during the experiment. After
loading, cells were diluted 1:5 in HBSS (plus CsA) and divided into
identical aliquots. At time zero the compound was added, and data
collected after the desired incubation times, exciting at 488 nm andmeasuring ﬂuorescence in the 542–585 nm interval. The contribution
of Q-7BTPI to this ﬂuorescence is negligible in comparison with that
of MitoSOX®. 10,000 cells were counted for each measurement, and
the median of the MitoSOX® ﬂuorescence distribution was deter-
mined and normalized to the value for time=0. The data plotted in
the various ﬁgures represent the averages±s.d. of N analogous
experiments.
It should be mentioned that MitoSOX® is a mitochondriotropic
compound, comprising a triphenylphosphonium group, which will
therefore be released from the mitochondria if they undergo depolar-
ization. It can therefore only provide semi-quantitative information
when depolarization is taking place. That the ﬂuorescence
increase caused by Q-7BTPI was due to superoxide production is
conﬁrmed by the effect of cell-permeant SuperOxide Dismutase (see
Results).
2.7. TMR ﬂuorescence assays
The ﬂuorescence of Jurkat lymphocytes loaded with tetramethylr-
hodamine methyl ester (TMRM; Invitrogen/Molecular Probes) was
measured by FACS. Procedures were as described above for
superoxide production assays, loading the cells with 20 nM TMRM
in the presence of 5 μM CsA for approximately 20 min at 37 °C.
10,000 cells were counted and the data treated as for MitoSOX®.
The contribution to the ﬂuorescence data by cell-bound Q-7BTPI in
this case is small but not negligible in comparison to the TMR ﬂuores-
cence. It was therefore measured in parallel experiments without dye,
and subtracted from the values obtained with TMRM.
2.8. Oxygen consumption assays
The rate of respiration by suspended Jurkat cells was measured in
polarographic assays using a Clark electrode inserted in a thermostat-
ted (25 °C) and stirred enclosed chamber with an illumination device
and an airtight injection port. The electrode was controlled by an
HansaTech CB1D control box and interfaced with a personal
computer by a Microlink 751 digitizer. Jurkat cells were used as a sus-
pension in HBSS or DMEM without serum, at the density of 3×106
cells/mL. In the experiments of Fig. 6B oligomycin (1 μg/mL) was
present in all cases to block phosphorylation-linked respiration and
thus facilitate detection of any uncoupling-induced increase of the
respiratory rate.
Oxygen consumption by adherent cells was measured using an
XF24 Extracellular Flux Analyzer (Seahorse, Bioscience) which mea-
sures in real time the oxygen consumption rate (OCR) in the medium
immediately surrounding adherent cells cultured in an XF 24-well
microplate. Adherent C-26 cells were seeded at 5×104 cells/well in
200 μL of supplemented culture medium (DMEM; Sigma Aldrich)
and incubated in a humidiﬁed atmosphere with 5% CO2 at 37 °C.
After an overnight incubation, the medium was replaced with
670 μL of pre-warmed (37 °C) DMEM. Microplates were incubated
at 37 °C for 30 min to allow media, temperature and pH to reach
equilibrium before the measurements. OCR was measured at preset
time intervals while the instrument automatically carried out the
pre-programmed additions of the various compounds (oligomycin
was 1 μg/mL ﬁnal concentration, FCCP 0.1 μM, Antimycin A 1 μM),
added as a solution in 70 μL of DMEM. All measurements were carried
out in quadruplicate (4 wells per condition).
2.9. ATP assay
Cellular ATP content was determined using the PerkinElmer
“ATPlite” kit according to the manufacturer's instructions. Brieﬂy,
Jurkat cells were resuspended in HBSS at a density of 3×105 cells/mL
and incubated for 3 h with or without 5 μM Q-7BTPI at 37 °C, 5% CO2.
Aliquots of 100 μL of cell suspension were placed in wells of a standard
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shaken at 700 rpm for 5 minutes, after which 50 μL of substrate
solution were added. After further shaking for 5 minutes and 15 mi-
nutes in the dark, the luminescence was measured with a Fluoroskan
Ascent FL (Thermo Electron Corporation) averaging the signal for
10 seconds.
2.10. Quantiﬁcation of free thiols
Jurkat cells were counted, washed with warm PBS, and incubated
for 1 h in HBSS with or without 5 μM Q-7BTPI. In another experimen-
tal setting, cells were pre-treated for 3 h with 10 mM GSHEE
(Glutathione Ethyl Ester, Sigma), and then treated for 1 h in HBSS
with or without 5 μM Q-7BTPI in the presence of GSHEE. Cells were
pelleted, and extracted with RIPA buffer (100–150 μL every 106
cells; composition: NaCl 150 mM, Tris/HCl 50 mM, Triton X-100 1%,
SDS 0.1%, sodium deoxycholate 0.5%, NaF 1 mM, EDTA 1 mM,
protease inhibitors cocktail (Roche), pH 7.4) for 40 minutes at 4 °C.
Samples were then centrifuged 5 min at 10,000 g and total protein
in the supernatants was estimated using the Folin method [24].
Cell extracts (180 μL) were deproteinized adding 100 μL of 6%
metaphosphoric acid; after 3–5 min in ice, samples were centrifuged
5 min at 10,000 ×g. Supernatants were collected, their volumes mea-
sured, and pH neutralized with Na3PO4 15%. Phosphate buffer (0.2 M,
pH 7.4, EDTA 5 mM) was added to each sample (to 1 mL ﬁnal vol-
ume); absorbance at 412 nm was measured before and after addition
of 30 μL DTNB (5-5'-dithiobis[2-nitrobenzoic acid]) 0.1 M [25]. Sam-
ple deproteinization assured selective detection of soluble free thiols,
mainly GSH. The amount of free thiols was calculated from the absor-
bance change using Lambert-Beer's law with 13.6 M−1 cm−1 as the
molar extinction coefﬁcient of DTNB, and normalized to the protein
content of each sample.
2.11. Glutathione reductase (GR) activity
In a cuvette, cell lysate (see above; 120 μg protein) and NADPH
(250 μM ﬁnal concentration) were added to TrisHCl buffer (0.2 M,
pH 8.1, 5 mM EDTA) (ﬁnal volume 0.5 mL). GR activity was started
adding 1 mM GSSG, and monitored at 25 °C as a decrease in NADPH
absorbance at 340 nm. The effect of Q-7BTPI on GR activity was
assessed by adding 50 μM Q-7BTPI to untreated Jurkat cells lysate
1 min before GSSG.
2.12. Glutathione peroxidase (GPx) activity
In a cuvette, cell lysate (800 μg protein), NADPH (250 μM ﬁnal
concentration), 25 nM Yeast Glutathione Reductase and 1 mM GSH
(both from Sigma) were added to HEPES buffer (50 mM, pH 7.0,
3 mM EDTA) (ﬁnal volume 0.5 mL). A GPx-catalyzed reaction was
started by adding 50 μM tert-butyl-hydroperoxide, and monitored
at 25 °C as a decrease in NADPH absorbance at 340 nm. The effect of
Q-7BTPI on GPx activity was assessed both adding 50 μM Q-7BTPI to
a lysate of untreated Jurkat cells (with no effect, not shown), and by
monitoring the activity of a lysate of Jurkat cells cultured for 1 h in
the presence of 5 μM Q-7BTPI.
2.13. Synthesis of 3,3′,4′,5-tetra-O-methyl,7-O-(4-
triphenylphosphoniumbutyl) quercetin iodide (QTM-7BTPI)
Methyl Iodide (1.0 mL, 16 mmol, 230 eq.) was added dropwise
and under continuous stirring to a mixture of Q-7BTPI (50 mg,
0.07 mmol, 1 eq.) and K2CO3 (100 mg, 0.7 mmol, 10 eq.) in CH3CN
(5 mL) and heated at 45 °C overnight. The solvent was than
eliminated under reduced pressure. The resulting yellow solid was
dissolved in the minimum amount of dichloromethane (1 mL) and
precipitated with diethyl ether (20 mL). The mixture was centrifugedand the precipitation was repeated 5 times. Residual solvent was then
removed under reduced pressure to afford the desired compound
(45 mg, 0.06 mmol) in 84% yield.
1H-NMR (250 MHz, CDCl3) δ (ppm): 1.91–2.01 (m, 2H, CH2),
2.27–2.35 (m, 2H, CH2), 3.73–3.81 (m, 2H, CH2), 3.86 (s, 3H, CH3),
3.94–3.99 (m, 9H, 3×CH3), 4.29 (t, 2H, CH2, 3JH-H=5.5 Hz), 6.24
(d, 1H, aromatic-H 4JH-H=2.3 Hz), 6.66 (d, 1H, aromatic-H 4JH-H=
2.3 Hz), 6.99 (d, 1H, aromatic-H, 3JH-H=8.8 Hz), 7.65–7.85 (m, 17H,
aromatic-H).
13C-NMR (62.9 MHz, CDCl3) δ (ppm): 19.2, 22.4 (d, 1J(13C/31P)=
50.9 Hz), 29.1 (d, 2J(13C/31P)=17.7 Hz), 55.9, 56.3, 56.6, 59.8, 67.3,
93.7, 95.7, 110.7, 111.0, 118.0 (d, 1J(13C/31P)=86.1 Hz), 121.8, 123.2,
130.5 (d, 2J(13C/31P)=12.5 Hz), 133.7 (d, 3J(13C/31P)=10.1 Hz), 135.1,
135.7, 141.0, 148.6, 150.7, 152.6, 158.6, 160.8, 162.9, 174.0.
ESI-MS: m/z 676, [M]+.
3. Results
3.1. Localization of Q-7BTPI
The triphenylphosphonium group efﬁciently targets the molecules
to which it is attached to the mitochondria [2,3]. On the other hand
the aromatic rings and hydroxyl groups of Quercetin favour its
binding to cellular components. To verify the expected mitochondrial
localization of Q-7BTPI we used ﬂuorescence microscopy. A weak
ﬂuorescence was elicited by excitation at 340 nm (Fig. 1A), or at
488 nm in a confocal microscope (Fig. 1B). In the latter case we took
advantage of the change of the absorption spectrum induced by
binding to cellular proteins (see Materials and Methods). The
images support a transmembrane voltage-dependent accumulation
into mitochondria, along with diffuse binding to other cellular
structures.
3.2. Cytotoxicity of Q-7BTPI
We assessed the cytotoxic/cytostatic effects of μM concentrations
of Q-7BTPI on cultured cells using the tetrazolium salt reduction
(MTT) assay. As controls, we checked also the action of Quercetin,
of a simple phosphonium salt (triphenylmethylphosphonium
chloride; TPMP) and of Quercetin plus TPMP. Three cell lines were
used: a murine colon cancer line (C-26), and fast- and slow-growing
immortalized Murine Embryonic Fibroblasts (MEF), non-tumoral cell
lines. Fig. 2 summarizes the results. The cytotoxic/cytostatic effect of
themitochondriotropic Quercetin derivative was evident, at concentra-
tions>1 μM, in the case of C-26 cells (Fig. 2A) and of fast-growing MEF
cells (Fig. 2B), while it was insigniﬁcant in that of slow-growing
MEF cells (Fig. 2C). Quercetin had a comparatively modest effect,
while TPMP did not have any impact either by itself or when added
together with Quercetin. The results of the MTT assay were conﬁrmed
by direct observation of the cell cultures at the microscope
(not shown).
3.3. Cell death induced by Q-7BTPI is necrotic
Cell death has traditionally been classiﬁed as either apoptosis or
necrosis. It is now clear that it can occur via a continuum of processes
including autophagic death, parthanatos, pyroptosis, etc. [26,27], but
a simpliﬁed distinction is maintained: at least as an approximation
apoptosis may be characterized as involving the caspase family of
proteases and in most cases the pro-apoptotic Bcl2-family proteins
Bax and/or Bak; on the contrary these proteins do not have a primary
role in necrosis.
To learn whether Q-7BTPI-induced death conforms more closely
to one or the other of these two models we veriﬁed whether the
toxic effects of the compounds would be reduced a) for Bax−/−/
Bak−/− MEFs in comparison with the corresponding parental strain
Fig. 2. Effect of quercetin derivatives and control compounds on the readout of MTT as-
says. Cells were allowed to grow for 3 days in the presence of the speciﬁed compounds
(see Materials and Methods for details). All measurements were performed in quadru-
plicate in each experiment. The data plotted are the averages±s.d. of the speciﬁed
number of experiments (N). A) C-26 mouse colon tumor cells. N=3–8. The readout
is signiﬁcantly different (p≤0.01) from control for Quercetin (Q), Q+
triphenylmethylphosphonium chloride (TPMP) and Q-7BTPI, 3 and 5 μM. B) Fast-
growing Mouse Embryonic Fibroblasts (MEF). N=3–10. The difference from control
is signiﬁcant for Q-7BTPI, 3 and 5 μM. C) Slow-growing MEF. N=3–8.
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fmk (Fig. 3C, D). For the former experiment we compared the results
of MTT reduction assays. Z-VAD-fmk has been reported to be toxic
itself if applied at high concentrations for prolonged periods, such
as the three days of our standard cell viability determination protocol
[28]. Therefore for the latter experiment we used FACS and Jurkat
cells, chosen as cell model because they grow in suspension, and
thus need not undergo a traumatic detachment before FACS analysis.
The cytotoxic effect of Q-7BTPI on these cells is documented in Fig. 3B.
Cell labelling by annexin and propidium iodide (PI) was quantiﬁedafter a 3 h exposure to our compound or to a paradigmatic apoptosis
inducer, staurosporine, with or without z-VAD-fmk.
With both approaches, the results with the mitochondriotropic
Quercetin derivative differed considerably from those with
apoptosis-inducing staurosporine. The readout of the MTT assay was
markedly altered by the absence of Bax and Bak when staurosporine
was used (note however that Bax−/−/Bak−/− DKO cells also suffer
in the presence of this aspeciﬁc kinase inhibitor), but not with
Q-7BTPI. In the annexin/PI labelling experiments, control incubation
in DMEM without serum for 3 h resulted in part (20% in the example
in Fig. 3C) of the cells being labelled by PI, annexin or both, a fraction
that was slightly reduced in the presence of z-VAD-fmk 100 μM. With
staurosporine the fractions of cells labelled by PI or by both PI and
annexin were similar to control, while, as expected, the percentage
of cells labelled by annexin only was much higher (63% vs. 7.2% in
the control in the example in Fig. 3C), and was drastically reduced
in the presence of z-VAD-fmk. With Q-7BTPI, conversely, annexin-
only labelling was similar to or below control levels, while a large
portion of the cells displayed labelling by both annexin and PI,
which was only slightly antagonized by z-VAD-fmk.
Incubation of Jurkat cells with 5 μMQ-7BTPI for 3 h resulted in a de-
crease of cellular ATP levels from 2.41±0.03 to 1.10±0.04 nmol/106
cells (a 54% reduction). Low ATP is one of the factors favoring necrosis
[29]. To verify whether the cells might be dying by “autophagic cell
death” [30] we compared induction of annexin/PI labelling of Jurkat
cells by Q-7BTPI in the absence or presence of two known inhibitors
of autophagy, 3-methyladenine [31] and chloroquine [32] (Suppl.
Fig. 1A). These inhibitors had little effect, inducing, if anything, a non-
signiﬁcant increase of labelling. In 3-day MTT viability assays 5 mM
3-MA or 30 μM Chloroquine reinforced the cytotoxic effect of Q-7BTPI
(not shown). Thus, the mechanisms of cell death in our experiments
appear to have more a necrotic than an apoptotic or autophagic
character. An involvement of the mitochondrial permeability transition
is unlikely in view of the lack of a signiﬁcant effect of Cyclosporin A
(CsA), the paradigmatic MPT inhibitor, in annexin/PI labelling experi-
ments (Suppl. Fig. 1B).
3.4. ROS production
Suspecting a prooxidant behavior of Q-7BTPI, we monitored
superoxide production in cells exposed to Q-7BTPI as ﬂuorescence
changes of the indicator MitoSOX® in FACS experiments with Jurkat
lymphocytes. Q-7BTPI was supplied at the highest concentration
used in cytotoxicity experiments, 5 μM. CsA, when present to exclude
possible effects due to onset of the MPT, modestly increased the
MitoSOX® response. CsH, which inhibits MDR pumps but not the
MPT pore, had the same effect, which can therefore be attributed to
a better retention within the cells of Q-7BTPI or MitoSOX®, or both
(Suppl. Fig. 2).
Fig. 4 presents the averages of the median values of MitoSOX®
ﬂuorescence distribution histograms obtained at the indicated times
after the addition of Q-7BTPI or control compounds (in the presence
of CsA). Only populations of cells were analyzed that displayed
forward- and side-scatter parameters characteristic of healthy cells,
i.e. cells not exhibiting morphological changes associated with
advanced necrosis or apoptosis. Thus the effects observed are not a
consequence of the death process, but rather precede or accompany
it, and can therefore be attributed to a direct action of the compounds.
3.5. ROS are responsible for cell death
The literature contains abundant evidence that ROS can cause cell
death [1]. To verify the role of ROS we checked whether decreasing
them would inﬂuence cell death. We tested a few permeant radical
scavengers (Trolox, TEMPOL, NAC, PEG-SOD) by comparing the
MitoSOX® response to our compounds in their presence. The best
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Fig. 3. Cells death is necrotic. A) The cytotoxic effect of mitochondriotropic quercetin derivatives is only slightly affected by the presence or absence of the pro-apoptotic proteins Bax
and Bak. MTT assay readout (N=3). 1000 WT or Bax−/−/Bak−/− (DKO) MEF cells were seeded in each well. Concentration of quercetin and derivatives was 5 μM, staurosporine
100 nM. B) Effect of Quercetin, Q-7BTPI and QTM-7BTPI on annexin/PI labeling of Jurkat cells in FACS experiments. Plotted is the percentage±s.d. of cells unlabelled by either annexin
or PI, relative to control (untreated). C, D) The pan-caspase inhibitor z-VAD-fmk has little effect on annexin/PI labelling of Jurkat cells treated with Q-7BTPI. FACS analysis of cells
exposed to 5 μM of the indicated agents (2 μM for staurosporine) for 3 h. Cells were pre-incubated for 30 minutes with or without z-VAD-fmk 100 μM; experiments were conducted
in DMEM without serum. C) One representative experiment out of ﬁve performed is shown. D) Averages±s.d. of the percentage of cells not labelled by either annexin or PI.
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(PEG-SOD) (Sigma). Incubation of Jurkat cells with 40 units/mL of
the reagent resulted in a marked reduction of the MitoSOX® response
to Q-7BTPI treatment (Fig. 5A). This result conﬁrms that the ROS0
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Fig. 4. Q-7BTPI elicits production of superoxide anion in Jurkat cells. Cells were incubated
in HBSS with 5 μM of the indicated compounds. N=3–7. MitoSOX® ﬂuorescence was
monitored by FACS.being detected in these experiments is mainly superoxide since it is
eliminated by superoxide dismutase.
Incubation with PEG-SOD also resulted in loss of the Q-7BTPI-
induced labelling by PI (and secondarily annexin) in FACS analyses
(Fig. 5B). We sought to determine whether cytotoxicity might be
ascribed to superoxide itself or to the major species derived from it,
i.e. H2O2. Inclusion of a high activity (200 or 500 U/mL) of Pegylated
Catalase (PEG-CAT) in the assay medium rescued the cells (Fig. 5C),
showing that the cytotoxic species is not O2·− but rather H2O2 formed
from it.
3.6. Effect on mitochondrial transmembrane potential
In agreement with previous observations [14], Q-7BTPI induced a
slowly-developing but marked loss of TMR ﬂuorescence from Jurkat
cells in FACS experiments (Fig. 6A), which ﬁnds a correspondence in
confocal microscopy experiments (Suppl. Fig. 3). Quercetin (5 μM)
induced a less pronounced ﬂuorescence decrease, which was not
potentiated by the simultaneous presence of 5 μM TPMP.
According to the chemiosmotic model of mitochondrial energy
transduction, a marked decrease of the Δμ̃H (of which the transmem-
brane potential, ΔΨm, is the major component) must be accompanied
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Fig. 5. Cell death is antagonized by reducing superoxide or hydrogen peroxide levels
with permeant enzymes. A) Permeant SOD reduces the Q-7BTPI-elicited MitoSOX®
ﬂuorescence response (superoxide production) in FACS experiments. Cells were
incubated with 40 U/mL PEG-SOD at 37 °C for 30 min before the addition of 5 μM
Q-7BTPI, as well as throughout the experiment (N=3). B) Incubation with PEG-SOD
(40 U/mL) reduces to control levels annexin/PI labeling of Jurkat cells exposed to
5 μM Q-7BTPI for 3 h in HBSS. The averages±s.d. of the percentage of cells not labeled
by either annexin or PI are shown. The results of treatment with Q-7BTPI plus or minus
PEG-SOD were signiﬁcantly different (p≤0.05). N=4. C) Incubation with PEG-CAT
(200 U/mL) also eliminates annexin/PI labeling. N=3.
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Fig. 6.Mitochondriotropic quercetin derivatives cause a decrease of the ﬂuorescence of
TMRM-labeled cells. TMR ﬂuorescence in Jurkat cells incubated with the indicated
compounds (5 μM unless otherwise stated) for the indicated times. FACS experiments.
(N=3–8).
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or the supply of respiratory substrates is limited. We therefore
veriﬁed whether Q-7BTPI had any effect on oxygen consumption. In
oxygraph experiments the respiration of Jurkat cells was only slightly
(non-signiﬁcantly) stimulated by up to 60 μMQ-7BTPI (Fig. 7A, B). No
signiﬁcant effect (either stimulation or inhibition) of 5 μM Quercetin
or Q-7BTPI could be detected using the oxygen indicator technique
(SeaHorse) and adherent C-26 cells either (Fig. 7C).
Previous work with isolated mitochondria has shown that the
mitochondriotropic Quercetin derivative Q-3BTPI can act as a proto-
nophoric uncoupling agent [14]. To verify whether the apparent loss
of in situ mitochondrial potential induced by Q-7BTPI might be
attributed to an analogous uncoupling cycle we compared the effect of
Q-7BTPI with that of its per-O-methylated derivative (3,3′,4′,5-tetra-
O-methyl,7-O-(4-triphenylphosphoniumbutyl) quercetin) (QTM-7-
BTPI). This latter compound accumulates in mitochondria, and thisaccumulation can be clearly observed (Suppl. Fig. 4). Since QTM-7BTPI
has no free hydroxyls, it cannot behave as a weak acid and as the
mediator of a futile protonophoric cycle, and it is not expected to act
as an uncoupler. Nonetheless it was found to induce a TMRﬂuorescence
loss analogous to that produced by Q-7BTPI, with a saturating behavior
reaching a maximum effect at 20 μM (Fig. 6B). The decreases of TMR
ﬂuorescence induced by 5 μM Q-7BTPI and 20 μM QTM-7BTPI were
comparable also in confocal microscopy experiments (Suppl. Fig. 3).
On the other hand QTM-7BTPI had no effect on theMitoSOX® response
(Suppl. Fig. 5A), did not promote labelling by annexin/PI (Fig. 3B), and
did not alter respiration by either Jurkat or C-26 cells (not shown).
Similarly, Quercetin-induced loss of TMR ﬂuorescence (Fig. 6A) was
accompanied by little (5 experiments out of 7) or no detectable
(2 experiments out of 7) superoxide production (Fig. 4) and increase
of annexin/PI labelling over a 3-h period (Fig. 3B).
Taken together, these observations suggested that the loss of TMR
ﬂuorescence induced by QTM-7BTPI, and at least part of that induced
by Quercetin and Q-7BTPI, might not actually reﬂect depolarization.
We veriﬁed whether TMRM ﬂuorescence is quenched by Q-7BTPI
and QTM-7BTPI in solution. This turned out not to be the case (Suppl.
Fig. 6). Other possibilities are that Q-7BTPI and QTM-7BTPI might
quench TMR ﬂuorescence only if both molecules are ﬁxed in neigh-
bouring positions due to binding to cellular structures, or that they
might compete with TMR for its binding sites [33], displacing it and
thereby promoting its partial loss from the cells. QTM-7BTPI
presumably competes for the same binding sites, although less efﬁ-
ciently due to the absence of hydroxyl groups capable of establishing
hydrogen bonds.
Indeed, the loss of TMR ﬂuorescence induced by 5 μM Q-7BTPI
+20 μM QTM-7BTPI was only modestly more pronounced than that
induced by 20 μM QTM-7BTPI itself in FACS experiments (Fig. 8A)
(a non-signiﬁcant difference). In the presence of 20 μM QTM-7BTPI
the same decrease of TMR ﬂuorescence was induced by 5 μM
Q-7BTPI and by 100 nM FCCP (Fig. 8A) (in the case of FCCP the differ-
ence with respect to control reached signiﬁcativity (p≤0.05)). This
Control
Quercetin
Q-7BTPI
Compound Oligomycin
FCCP
Antimycin A
120
100
80
60
40
20
0
-20
-40
-60
-80
-100
ΔO
CR
 (%
)
0 40 80 120 160
Time (min)
0 500 1000 1500 2000 2500 3000
160
170
180
190
200
210
220
230
240
+Q-7BTPI 20 μM
+Q-7BTPI 20 μM
+Q-7BTPI 15 μM
+Q-7BTPI 5 μM
[O
2](
μM
)
Time (sec)
% control
0 50 100 150
CONTROL
Q-7BTPI
FCCP 100nM
A
B
C
Fig. 7. Q-7BTPI has no marked effects on the respiration of cultured cells. A) A repre-
sentative oxygraph experiment showing the lack of effect of successive additions of
Q-7BTPI, up to 60 μM, on the oxygen consumption rate (OCR) by Jurkat cells. B) 5 μM
Q-7BTPI or 100 nM FCCP cause at most a slight increase in the OCR by Jurkat cells.
Respiration rates are expressed as percentage of the control (cells treated with
oligomycin only) rate. The difference with respect to control is not signiﬁcant in the
case of Q-7BTPI, while it is in that of FCCP (p≤0.05). N=4–5. C) Rate of respiration
by C-26 cells as determined using the oxygen indicator technique. A representative
experiments out of seven performed (using various addition sequences) is shown.
For presentation purposes the data were normalized to the initial OCR baseline
measurement for each set of wells and are presented as % changes with respect to
that level. The addition of 5 μM Q-7BTPI or quercetin to one set of wells was followed
as indicated by the addition to the same set of wells and to a control set of a)
oligomycin to inhibit oxidative phosphorylation, b) FCCP to maximally increase
mitochondrial respiration, and c) antimycin to completely abolish it.
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Fig. 8. 5 μM Q-7BTPI causes no or only a minor loss of mitochondrial potential in Jurkat
cells. Median TMR ﬂuorescence values from FACS experiments analogous to those
shown in other ﬁgures. N=3–8. A) 5 μM Q-7BTPI or 100 nM FCCP induce a similar
and modest loss of TMR ﬂuorescence in addition to the decrease caused by 20 μM
QTM-7BTPI, which is tentatively attributed to displacement of bound TMR. B) 5 μM
Q-7BTPI or 100 nM FCCP induce very different extents of TMR ﬂuorescence loss if
QTM-7BTPI is not present.
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Q-7BTPI when the TMR ﬂuorescence assay was conducted without
QTM-7BTPI (Fig. 8B). At variance from Q-7BTPI, 100 nM FCCP induced
a signiﬁcant increase of respiration with respect to control both with
Jurkat cells (Fig. 7B) and with adherent C-26 cells (Fig. 7C).We conclude therefore that: a) most of the loss of TMR ﬂuorescence
induced by Q-7BTPI is actually due to displacement or quenching of
bound TMR; b) in our experiments 100 nM FCCP induces a depolariza-
tion and respiratory stimulation which are close to or, if anything,
greater than those elicited by 5 μM Q-7BTPI.3.7. The origin of ROS
How are ROS generated? The mitochondrial respiratory chain
produces ROS, and the literature contains reports of increased ROS
production following both inhibition of the electron ﬂow due to a
ΔμH̃ increase or its stimulation following a ΔμH̃ decrease by
uncoupling (rev.: [34]). Since, as we just concluded, Q-7BTPI causes
a slight depolarization, we sought to determine if this could quantita-
tively account for ROS production by comparison with the effects of
well-known mitochondrial uncouplers.
In FACS experiments assessing MitoSOX® ﬂuorescence to monitor
superoxide production and TMR ﬂuorescence as a reporter of
transmembrane potential we observed an increase of the former
accompanying a decrease of the latter when using the classical proto-
nophoric uncouplers FCCP (Fig. 9) or DNP (Suppl. Fig. 7). The increase
of MitoSOX® ﬂuorescence was indeed due to the production of super-
oxide because it was completely eliminated by PEG-SOD (not shown).
Note however that with 100 nM FCCP MitoSOX® ﬂuorescence at
120 min, although signiﬁcant, was only 11% higher than control.
5 μM Q-7BTPI—with similar or lower effects on transmembrane
potential and respiration—caused an increase by 400–500% (Figs. 4
and 5). Thus, taken together, the results indicate that only a small
fraction of superoxide production in our system can be linked to
mitochondrial depolarization.
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Fig. 9. Depolarization by the protonophoric mitochondrial uncoupler FCCP is accompa-
nied by generation of superoxide. A) MitoSOX® and B) TMR ﬂuorescence response to
increasing [FCCP] in Jurkat cells. Data from the same FACS experiments. N=3.
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particular with Antimycin A (Suppl. Fig. 8). Our experiments monitor-
ing respiration (Fig. 7) however did not provide any evidence of an
inhibition of oxygen consumption by 5 μM Q-7BTPI. ROS production
may a priori also be downstream of a dysregulation of Ca2+ homeosta-
sis [35] or, viceversa, excessive ROS may cause dysregulation of Ca2+
[36] which may result in cell death [37]. Such a dysregulation may
take place in cells exposed to Quercetin and H2O2 [38]. To verify
whether alterations of Ca2+ levels may have a prominent role in Q-
7BTPI-induced cell death we checked whether membrane-permeable
Ca2+ chelators would inﬂuence superoxide production and/or cell
death. The MitoSOX® response to Q-7BTPI was unaffected or, at higher
concentrations, slightly increased by BAPTA-AM and EGTA-AM, sug-
gesting that ROS production is not caused by excessive cytoplasmic
or mitochondrial Ca2+ (Suppl. Fig. 9). These same permeant chelators
either did not alter or, at the higher concentrations used, accentuated
the cytotoxic effects of Q-7BTPI (not shown), suggesting that high
[Ca2+] is not a proximal cause of cell death in our system.
The inertness of QTM-7BTPI at this point suggests (although it
does not prove) that oxidation of the ﬂavonoid nucleus may be
involved in the generation of ROS (see discussion). Metal ions may
catalyze oxidative reactions leading to the consumption of polyphenol
with the generation of superoxide [16,39,40]. We therefore veriﬁed
whether incubation of the cells with membrane-permeant iron
(VK28, deferiprone) and copper (TPEN, Neocuproine) chelators
would affect MitoSOX® response. These compounds proved cytotoxic
at relatively high concentrations (not shown). At non-toxic levels,
they did have a partial effect on the MitoSOX® response (Suppl. Fig.
10), suggesting the possible participation of metal ions in the genera-
tion of ROS.
3.8. Effects on the glutathione system
Glutathione (GSH), the major cellular antioxidant molecule, has
been reported to have a direct role in regulating ROS production bymitochondria (rev.: [41]), and imbalances in the levels of glutathione
have been linked to oxidative stress-induced death induction (e.g.
[42,43]). GSH reacts to reduce hydrogen peroxide (the toxic species
in our case) to water with catalysis by GPx. The oxidation product,
GSSG, can be reduced to GSH by Glutathione Reductase, which uses
reducing equivalents provided by NADPH.
In our hands, treatment of Jurkat cells (3×105 cells/mL) with 5 μM
Q-7BTPI for 1 h decreased GSH from 13.9±2.3 to 10.4±0.4 nmoles/
mg.prot. Pre- and co-incubation with 10 mM GSHEE, a permeable
precursor of glutathione, from which GSH can be regenerated by
cellular esterases, increased cellular GSH levels to 250±14 and
271±25 nmoles/mg.prot. for otherwise untreated and Q-7BTPI treated
cells, respectively. This was accompanied by a modest decrease of the
MitoSOX® response elicited by Q-7BTPI (Suppl. Fig. 11A; the difference
with respect to control however was not signiﬁcant at the 2-h time
point), while no difference was observed in annexin/PI labelling after
3 h (Suppl. Fig. 11B). Both the small reduction of GSH levels by
Q-7BTPI and the modest effect of a strong increase of cellular GSH
levels on annexin/PI labeling may be explained by the inhibition of
some enzymes of the glutathione system by ﬂavonoids. The literature
reports that high (100 μM range) concentrations of Quercetin inhibit
GR from various sources [44–46], even upon in vivo long-term admin-
istration [47]. Quercetin also inhibits at least Glutathione-S-Transferase
[44,48], and, at sub-μM levels, Thioredoxin Reductase [49]. Flavonoids
are also known to inhibit peroxidases [50]. Our mitochondriotropic
compounds accumulate in both cytoplasm and mitochondria and
may reach concentrations sufﬁcient for an inhibitory effect. Indeed,
Q-7BTPI inhibited GR activity in Jurkat cell lysate by 50% at 50 μM,
and GPx activity was also inhibited by about 80% after 1-h incubation
of the cells with 5 μM Q-7BTPI, in agreement with the known
sensitivity of this selenoenzyme to O2·- [51].
4. Discussion
The starting point of this investigation was the observation that
Q-7BTPI can be cytotoxic when supplied to cultured cells in the low-
μM range (Fig. 2). The effect appears to have a non-linear dependence
on dosage, and to be selective for cancerous/rapidly growing cells, as
typical of chemotherapeutic drugs. Since it does not depend on the
expression of Bax and Bak, and it is not affected by the pan-caspase
inhibitor ZVAD-fmk (Fig. 3), death can be classiﬁed as non-apoptotic.
A possible alternative, autophagic cell death, is not supported by exper-
iments with inhibitors of protein degradation (Suppl. Fig. 1A).
Autophagy is widely believed to be a rescue process cells engage in
when severely stressed, but the idea that it may also be itself a
mechanism for cellular “suicide” is beginning to be challenged [52].
Q-7BTPI-induced death thus appears to have a necrosis-like character,
possibly classiﬁable as autoschizis [53].
A cytotoxicity of Quercetin in the tens-of-μM range for cultured
cancer cells has been reported in several publications (e.g. [54–58]),
and shown in some cases to be cell-type dependent [59,60]. Quercetin
may exhibit pro-death cancer-selective action also in in vivo models
[61]. The multiple mechanisms involved have not been always
clariﬁed. A pro-oxidant action may take place [62], but it has been ex-
cluded in several studies (e.g. [58–60]). In fact, Quercetin has been
recognized to act as an antioxidant at relatively low (roughlyb50 μM)
concentrations, and as a prooxidant at higher levels (e.g. [19,63,64]).
When present under oxidative stress, Quercetin may act as a radical
scavanger, becoming oxidized to quinones, which are toxic because
they can react with cell thiols [38,65] and form DNA adducts [66].
In our case the role of oxidative stress—or more speciﬁcally of
superoxide and hence H2O2 production—is fundamental, given that
permeant SOD or CAT can rescue the cells almost completely
(Fig. 5). Rescue by PEG-CAT indicates that the actual toxic agent is
H2O2 (or species derived from it). A major cytotoxic role of Quercetin
quinones is unlikely because of the lack of protection by the high
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GSH would be expected to react with the quinones, preventing their
reaction with more crucial targets. In general, GSH is a major determi-
nant of a cell's redox status, its role being that of contrasting oxidative
phenomena. The effects of ﬂavonoids on GSH levels in cultured cells
seem to depend on cell type and on the experimental procedures.
Quercetin (5–25 μM) has been reported to reduce the GSH content
in three human leukemia cell lines, but not in a fourth [67], to either
have no effect [68] or produce an increase [69] in cultured neurons,
and to increase GSH in cultured astrocytes [68]. In our Jurkat cells
5 μM Q-7BTPI induced a decrease, but the alteration was minor, and
can hardly explain toxicity, as conﬁrmed by the lack of effect of the
exogenous GSHEE precursor. Considerable relevance may instead be
tentatively ascribed to the observed inhibition of GPx. This enzymes
detoxiﬁes peroxides, including H2O2. Its inactivation may therefore
represent a key feature of cytotoxic action.
Other potential mechanisms of cytotoxicity exist which do not
involve direct effects on the redox poise. For example, Quercetin
binds to [70] and at high concentrations inhibits [71] the
mitochondrial ATPase, as well as many kinases (e.g. [72]), and its mito-
chondriotropic derivatives may be expected to do the same. However,
induction of redox stress appears to be the fastest-acting lethal
pathway under our conditions. Prooxidant effects of this type, resulting
in either apoptosis or necrosis, have been reported for various
redox-active compounds (e.g. [73–75]). The protective effect of PEG-
SOD is noteworthy. SOD catalyzes the conversion of O2·- to H2O2 and
O2. If H2O2 is toxic, how can rescue (Fig. 5B) be explained? We return
to this question below.
Superoxide production is speciﬁcally associated with the mitochon-
driotropic compound, since Quercetin or the combination of Quercetin
and a phosphonium salt do not have a comparable effect (Fig. 4). Since
the redox properties and reactivity of Q-7BTPI are very close to those of
Quercetin [12], andMitoSOX®measures mitochondrial superoxide, the
abundant production of radicals presumably has to do with the
concentration of Q-7BTPI in mitochondria. This accumulation can be
observed by microscopy (Fig. 1) despite the unfavorable optical
properties of the compound. It is furthermore conﬁrmed by the behav-
ior of analogous compounds such as QTM-7BTPI (Suppl. Fig. 4) andRespiratory
chain
Fig. 10. A partial representation of the redox reactions proposed to take place in cells exposed
text for details.QTA-7BTPI [11], and by the displacement or quenching of mitochondri-
al TMR (see below). A difference in the levels of accumulation of
Q-7BTPI in the mitochondria of the various cell types, due to differ-
ences in the mitochondrial transmembrane potential, might help
explain the selectivity of the cytotoxic action. Cancerous cells have
been reported to maintain a higher mitochondrial potential (see
discussion in [76]). If concentrations in the μM range can be achieved
in vivo, at least locally, they are likely to have the cytotoxic effect
described in this paper which may be put to use to ﬁght established
cancer. These aspects are under investigation.
The evaluation of the effects of Q-7BTPI on the mitochondrial po-
tential proved complex. The pronounced loss of TMR ﬂuorescence
we observed seemed in accordance with the protonophoric futile
cycle desumed to take place with isolated mitochondria and
Q-3BTPI [14], but was hard to reconcile with the lack of a marked
effect (either stimulation or inhibition) on respiration. Furthermore,
the permethylated analog QTM-7BTPI, which cannot act as a protono-
phore, caused a similar loss of TMR ﬂuorescence, although at higher
concentrations, while producing none of the other effects of
Q-7BTPI. In the presence of saturating levels of QTM-7BTPI, Q-7BTPI
had a more modest effect on the residual TMR ﬂuorescence in Jurkat
cells, quantitatively similar to that caused by 100 nM FCCP. We have
tentatively rationalized these observations in terms of a competition
by Q-7BTPI (and, less effectively, by QTM-7BTPI as well as by
Quercetin) for TMR binding sites in the cells and mitochondria, or,
equivalently, of an in situ ﬂuorescence quenching. The actual effect
on the transmembrane potential appears to be relatively modest.
This suggests that uncoupling via protonophoric cycling mediated
by Q-7BTPI is not very efﬁcient in intact cells, perhaps precisely
because a large fraction of Q-7BTPI binds to cellular structures.
A major mechanistic question is how superoxide is produced. The
lack of generation of ROS by the tetramethylated derivative suggests
that superoxide production is dependent on the presence of
oxidizable groups on the Quercetin derivative. It must on the other
hand have to do with concentration of Q-7BTPI in the mitochondria,
and, as mentioned, the concentration of oxidizable species can itself
be a factor in determining prooxidant behavior. A comparison of the
MitoSOX® ﬂuorescence response with that elicited by 100 nM FCCPto Q-7BTPI. Only some of the possibilities for initiation and termination are shown. See
1105N. Sassi et al. / Biochimica et Biophysica Acta 1817 (2012) 1095–1106(Fig. 8) indicates that ROS production cannot be generically linked to
the induction of mitochondrial depolarization.
The polyphenol moiety may well become oxidized in the mito-
chondrial environment, perhaps in a reversible manner acting as a
redox cycler [16,39]. Which speciﬁc mitochondrial factors are in-
volved remains to be determined. Mitochondria maintain a slightly
more alkaline pH in the matrix with respect to the cytoplasm, and
this would be expected to favor oxidation of phenolic groups. They
are rich in copper- and iron-containing groups, which a priori may
serve as mediators in electron transfer from the polyphenolic species
to oxygen (see Suppl. Fig. 10). They are the seat of intense enzymatic
redox activity which may involve polyphenols.
Although the respiratory chain was not inhibited under our
experimental conditions (5 μM Q-7BTPI, energized mitochondria)
(Fig. 7), this does not rule out a role of the respiratory chain in ROS
generation. Indeed, evidence has been presented of an interaction of
Quercetin with at least Complex I and cytochrome c [77]. In the case
of Q-7BTPI, an analogous interaction with Complex I or another
component of the respiratory chain might result in the diversion of
a small portion of the electron ﬂow to oxygen to produce superoxide
radical anion, or in the oxidation of the Quercetin moiety. Either pro-
cess might potentially serve as an initiation point for a chain “autoox-
idation” such as the one proposed in Fig. 10. In this scheme, the major
source of superoxide anion is a cyclic reaction in which superoxide is
generated via transfer of an electron from the semiquinone of the
Quercetin derivative to oxygen, and in turn regenerates the semiqui-
none by oxidizing a Quercetin moiety, with the concomitant
production of H2O2. Such cyclic redox processes have been proposed
before [39,40,78]. This mechanism is attractive because it can explain
why PEG-SOD protects cells even though it can only help the
production of toxic hydrogen peroxide: the dismutation it catalizes
constitutes a termination step for the chain reaction which consumes
Q-7BTPI and oxygen to produce Q-7BTPI quinones and H2O2. “Linear”
schemes such as quantitative production of superoxide via reduction
of oxygen by the respiratory chain would not account for the observa-
tion. Since this termination step competes directly with the propaga-
tion reaction between O2.- and the polyphenol, an increase in the
concentration of the latter, as occurs for Q-7BTPI inside mitochondria,
is expected to facilitate propagation, i.e., to increase autooxidation.
This, along with the favourable mitochondrial environment, explains
why Q-7BTPI induces a stronger production of ROS than Quercetin.
At lower levels, a lesser ROS production may result not in cytotox-
icity but in an hormetic effect. In fact Quercetin and its glycosylated
derivatives have been associated with Nrf2 activation in some reports
[79,80]. A hormetic actionmay account for the interesting antioxidant
effects of the in vivo administration of another class of mitochondria-
targeted polyphenolic compounds, the plastoquinones developed by
Skulachev's group [4].
In summary, we have shown that Q-7BTPI at the μM level induces
a necrotic type of cell death. Death is caused by ROS, speciﬁcally by
H2O2 or reactive species derived from it. Inhibition of Glutathione
Peroxidase may contribute to redox stress. At least in the short
term, Q-7BTPI itself has only a small effect on the mitochondrial
potential and on respiration. While the mechanism of ROS generation
requires further investigation, and the possible role of respiratory
complexes needs to be investigated, a chain reaction consuming
Q-7BTPI is consistent with the available data. Possible in vivo applica-
tions of this and similar compounds as an anti-cancer and/or a hor-
metic agent are worth considering.
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